Trastornos del sistema nervioso Poco frecuente: Cefalea No conocida: Convulsiones *, Mareo Trastornos cardiacos No conocida: Palpitaciones Trastornos vasculares Poco frecuente: Hipertensin, Hipotensin Trastornos respiratorios, torcicos y mediastnicos No conocida: Disnea Trastornos gastrointestinales Frecuente: Vmitos, Nuseas, Diarrea, Dolor abdominal Poco frecuente: Disgeusia, Dispepsia, Boca seca Trastornos de la piel y del tejido subcutneo Poco frecuente: Olor cutneo anormal ** No conocida: Prurito, Erupcin cutnea Trastornos musculoesquelticos y del tejido conjuntivo Poco frecuente: Espasmos musculares No conocida: Miastenia***, Tensin muscular Trastornos generales y alteraciones en el lugar de administracin Poco frecuente: Dolor torcico, Sensacin extraa, Pirexia, Reaccin en el lugar de inyeccin**** Exploraciones complementarias Poco frecuente: Aumento de la presin arterial Muy rara: Aumento del INR*****
Wegovy : Side effects and safety While GLP-1 medications like tirzepatide and Wegovy tend to share similar side effects, how often they occur can vary by medication and dose
Wegovy was approved in June 2021
For those interested in next-generation options, retatrutide is a triple-receptor agonist currently in clinical trials that targets GLP-1, GIP, and glucagon receptors
An 'enormous' cost The high price of GLP-1 drugs - which are patented, meaning cheaper copycat versions can't be made - has led to a debate among insurance companies, said Benjamin Rome, a health policy researcher at Harvard Medical School
Save the calculation you just ran
